8-K Announcements
6May 5, 2026·SEC
Feb 10, 2026·SEC
Feb 10, 2026·SEC
Astera Labs, Inc. Common Stock (ALAB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Astera Labs, Inc. Common Stock (ALAB) stock price & volume — 10-year historical chart
Astera Labs, Inc. Common Stock (ALAB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Astera Labs, Inc. Common Stock (ALAB) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.61vs $0.54+13.6% | $308Mvs $292M+5.5% |
| Q1 2026 | Feb 10, 2026 | $0.58vs $0.52+12.4% | $271Mvs $250M+8.4% |
| Q4 2025 | Nov 4, 2025 | $0.49vs $0.39+25.7% | $231Mvs $206M+11.7% |
| Q3 2025 | Aug 5, 2025 | $0.44vs $0.32+35.8% | $192Mvs $172M+11.3% |
Astera Labs, Inc. Common Stock (ALAB) competitors in Analog, Mixed-Signal and RF Chips — business model, growth, and fundamentals comparison
Astera Labs, Inc. Common Stock (ALAB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Astera Labs, Inc. Common Stock (ALAB) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
| Sales/Revenue | 79.87M | 115.79M | 396.29M | 852.52M | 1B |
| Revenue Growth % | - | 44.97% | 242.24% | 115.13% | 104.18% |
| Cost of Goods Sold | 21.19M | 35.97M | 93.59M | 207.26M | 240.45M |
| COGS % of Revenue | 26.53% | 31.06% | 23.62% | 24.31% | - |
| Gross Profit | 58.68M▲ 0% | 79.83M▲ 36.0% | 302.7M▲ 279.2% | 645.26M▲ 113.2% | 760.99M▲ 0% |
| Gross Margin % | 73.47% | 68.94% | 76.38% | 75.69% | 75.99% |
| Gross Profit Growth % | - | 36.04% | 279.19% | 113.17% | - |
| Operating Expenses | 118.88M | 109.32M | 418.76M | 471.84M | 537.02M |
| OpEx % of Revenue | 148.83% | 94.41% | 105.67% | 55.35% | - |
| Selling, General & Admin | 45.16M | 35.92M | 217.94M | 167.84M | 171.94M |
| SG&A % of Revenue | 56.55% | 31.02% | 54.99% | 19.69% | - |
| Research & Development | 73.71M | 73.41M | 200.83M | 304M | 365.08M |
| R&D % of Revenue | 92.29% | 63.39% | 50.68% | 35.66% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -60.19M▲ 0% | -29.5M▲ 51.0% | -116.07M▼ 293.5% | 173.42M▲ 249.4% | 223.97M▲ 0% |
| Operating Margin % | -75.36% | -25.47% | -29.29% | 20.34% | 22.36% |
| Operating Income Growth % | - | 51% | -293.48% | 249.42% | - |
| EBITDA | -59.39M | -27.72M | -112.91M | 180.25M | 233.42M |
| EBITDA Margin % | -74.35% | -23.94% | -28.49% | 21.14% | 23.31% |
| EBITDA Growth % | - | 53.33% | -307.39% | 259.64% | 1386.13% |
| D&A (Non-Cash Add-back) | 807K | 1.78M | 3.15M | 6.83M | 9.45M |
| EBIT | -60.19M | -29.5M | -116.07M | 218.15M | 247.38M |
| Net Interest Income | 2.61M | 6.55M | 34.29M | 44.73M | 45.88M |
| Interest Income | 2.61M | 6.55M | 34.29M | 44.73M | 45.88M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.61M | 6.55M | 34.29M | 44.73M | 45.88M |
| Pretax Income | -57.58M▲ 0% | -22.95M▲ 60.1% | -81.78M▼ 256.4% | 218.15M▲ 366.8% | 269.85M▲ 0% |
| Pretax Margin % | -72.09% | -19.82% | -20.64% | 25.59% | 26.95% |
| Income Tax | 764K | 3.31M | 1.64M | -981K | 2.23M |
| Effective Tax Rate % | -1.33% | -14.42% | -2.01% | -0.45% | 0.82% |
| Net Income | -58.34M▲ 0% | -26.26M▲ 55.0% | -83.42M▼ 217.7% | 219.13M▲ 362.7% | 267.63M▲ 0% |
| Net Margin % | -73.05% | -22.68% | -21.05% | 25.7% | 26.72% |
| Net Income Growth % | - | 55% | -217.71% | 362.68% | 546.55% |
| Net Income (Continuing) | -58.34M | -26.26M | -83.42M | 219.13M | 267.63M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.45▲ 0% | -0.17▲ 62.2% | -0.64▼ 276.5% | 1.22▲ 290.6% | 1.48▲ 0% |
| EPS Growth % | - | 62.22% | -276.47% | 290.63% | 563.68% |
| EPS (Basic) | -0.45 | -0.17 | -0.64 | 1.32 | - |
| Diluted Shares Outstanding | 130.45M | 152.5M | 131.26M | 179.55M | 181.16M |
| Basic Shares Outstanding | 130.45M | 152.5M | 131.26M | 166.41M | 170.73M |
| Dividend Payout Ratio | - | - | - | - | - |
Astera Labs, Inc. Common Stock (ALAB) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
| Total Current Assets | 206M | 185.81M | 1.01B | 1.36B | 1.41B |
| Cash & Short-Term Investments | 163.14M | 149.31M | 914.3M | 1.19B | 1.18B |
| Cash Only | 76.09M | 45.1M | 79.55M | 167.61M | 148.28M |
| Short-Term Investments | 87.06M | 104.22M | 834.75M | 1.02B | 1.04B |
| Accounts Receivable | 10.72M | 8.34M | 38.81M | 83.2M | 134.8M |
| Days Sales Outstanding | 48.99 | 26.27 | 35.75 | 35.62 | 25.99 |
| Inventory | 28.87M | 24.09M | 43.22M | 58.98M | 60.16M |
| Days Inventory Outstanding | 497.33 | 244.52 | 168.54 | 103.86 | 87.06 |
| Other Current Assets | 509K | 686K | 16.65M | 31.03M | 33.51M |
| Total Non-Current Assets | 5.73M | 10.48M | 41.53M | 169.79M | 246.28M |
| Property, Plant & Equipment | 3.52M | 7.58M | 35.65M | 92.04M | 97.17M |
| Fixed Asset Turnover | 22.67x | 15.27x | 11.12x | 9.26x | 12.37x |
| Goodwill | 0 | 0 | 0 | 0 | 87.72M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.2M | 2.9M | 5.88M | 77.75M | 206.26M |
| Total Assets | 211.73M▲ 0% | 196.29M▼ 7.3% | 1.05B▲ 437.2% | 1.53B▲ 45.3% | 1.66B▲ 0% |
| Asset Turnover | 0.38x | 0.59x | 0.38x | 0.56x | 0.68x |
| Asset Growth % | - | -7.29% | 437.21% | 45.26% | 174.59% |
| Total Current Liabilities | 40.09M | 35.08M | 86.54M | 133.04M | 125.04M |
| Accounts Payable | 10.29M | 6.34M | 26.92M | 42.36M | 55.82M |
| Days Payables Outstanding | 177.32 | 64.31 | 104.98 | 74.6 | 59.04 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 15M | 0 | 10M |
| Other Current Liabilities | 9.71M | 11.66M | 37.92M | 90.68M | 69.23M |
| Current Ratio | 5.14x | 5.30x | 11.71x | 10.24x | 10.24x |
| Quick Ratio | 4.42x | 4.61x | 11.21x | 9.79x | 9.79x |
| Cash Conversion Cycle | 369 | 206.48 | 99.3 | 64.89 | 54.01 |
| Total Non-Current Liabilities | 256.93M | 3.79M | 3.17M | 35.15M | 40.22M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 778K | 0 | 35.15M | 62.03M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 256.93M | 3.01M | 3.17M | 0 | 44.26M |
| Total Liabilities | 297.02M | 38.87M | 89.71M | 168.19M | 165.27M |
| Total Debt | 1.6M | 2.93M | 1.29M | 35.15M | 0 |
| Net Debt | -74.49M | -42.16M | -78.27M | -132.46M | -148.28M |
| Debt / Equity | - | 0.02x | 0.00x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | 0.19x | 0.00x |
| Net Debt / EBITDA | - | - | - | -0.73x | -0.73x |
| Interest Coverage | - | - | - | - | - |
| Total Equity | -85.29M▲ 0% | 157.43M▲ 284.6% | 964.8M▲ 512.9% | 1.36B▲ 41.3% | 1.49B▲ 0% |
| Equity Growth % | - | 284.57% | 512.86% | 41.34% | 162.09% |
| Book Value per Share | -0.65 | 1.03 | 7.35 | 7.59 | 8.25 |
| Total Shareholders' Equity | -85.29M | 157.43M | 964.8M | 1.36B | 1.49B |
| Common Stock | 4K | 4K | 16K | 17K | 17K |
| Retained Earnings | -99.12M | -125.38M | -208.8M | 10.34M | 90.65M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -229K | 259K | 426K | 4.31M | -780K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
Astera Labs, Inc. Common Stock (ALAB) cash flow — operating, investing & free cash flow history
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|
| Cash from Operations | -35.9M | -12.72M | 136.68M | 319.31M | 319.31M |
| Operating CF Margin % | -44.94% | -10.98% | 34.49% | 37.45% | - |
| Operating CF Growth % | - | 64.58% | 1174.83% | 133.62% | 1127.27% |
| Net Income | -58.34M | -26.26M | -83.42M | 219.13M | 267.63M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M | 6.57M |
| Stock-Based Compensation | 30.23M | 10.68M | 234.59M | 160.03M | 125.13M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.38M | 10.76M | -4.35M | -726K | -12.34M |
| Working Capital Changes | -9.97M | -9.68M | -13.29M | -65.96M | -3.58M |
| Change in Receivables | -6.04M | 2.39M | -30.48M | -44.34M | -65.16M |
| Change in Inventory | -19.36M | -5.56M | -19.29M | -12.95M | -5.82M |
| Change in Payables | 2.13M | -4.26M | 20.89M | 14.19M | 11.27M |
| Cash from Investing | -90.59M | -17.77M | -757.57M | -241.47M | -331.54M |
| Capital Expenditures | -3.87M | -2.76M | -34.24M | -37.54M | -40.59M |
| CapEx % of Revenue | 4.85% | 2.38% | 8.64% | 4.4% | - |
| Acquisitions | 0 | 0 | 0 | -28.79M | -93.83M |
| Investments | - | - | - | - | - |
| Other Investing | 0 | 0 | -1.41M | -500K | -3M |
| Cash from Financing | 151.67M | -502K | 655.84M | 9.8M | 9.5M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 149.55M | -210K | 671.13M | 9.8M | 13.76M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -313K | -210K | -1.07M | 0 | 0 |
| Other Financing | 2.12M | -292K | -15.29M | 0 | -4.26M |
| Net Change in Cash | 25.18M▲ 0% | -30.99M▼ 223.1% | 34.95M▲ 212.8% | 87.64M▲ 150.8% | 61.29M▲ 0% |
| Free Cash Flow | -39.77M▲ 0% | -15.48M▲ 61.1% | 102.43M▲ 761.8% | 281.76M▲ 175.1% | 342.81M▲ 0% |
| FCF Margin % | -49.79% | -13.37% | 25.85% | 33.05% | 34.23% |
| FCF Growth % | - | 61.08% | 761.83% | 175.07% | 216.92% |
| FCF per Share | -0.30 | -0.10 | 0.78 | 1.57 | 1.57 |
| FCF Conversion (FCF/Net Income) | 0.62x | 0.48x | -1.64x | 1.46x | 1.28x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 2.48M | 7.79M | 0 | 0 |
Astera Labs, Inc. Common Stock (ALAB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
| Return on Equity (ROE) | -72.8% | -14.87% | 18.82% | 20.33% |
| Return on Invested Capital (ROIC) | -19.19% | -17.38% | 12.28% | 12.28% |
| Gross Margin | 68.94% | 76.38% | 75.69% | 75.99% |
| Net Margin | -22.68% | -21.05% | 25.7% | 26.72% |
| Debt / Equity | 0.02x | 0.00x | 0.03x | 0.03x |
| FCF Conversion | 0.48x | -1.64x | 1.46x | 1.28x |
| Revenue Growth | 44.97% | 242.24% | 115.13% | 104.18% |
Astera Labs, Inc. Common Stock (ALAB) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Feb 10, 2026·SEC
Feb 10, 2026·SEC
Astera Labs, Inc. Common Stock (ALAB) stock FAQ — growth, dividends, profitability & financials explained
Astera Labs, Inc. Common Stock (ALAB) reported $1.00B in revenue for fiscal year 2025. This represents a 1154% increase from $79.9M in 2022.
Astera Labs, Inc. Common Stock (ALAB) grew revenue by 115.1% over the past year. This is strong growth.
Yes, Astera Labs, Inc. Common Stock (ALAB) is profitable, generating $267.6M in net income for fiscal year 2025 (25.7% net margin).
Astera Labs, Inc. Common Stock (ALAB) has a return on equity (ROE) of 18.8%. This is reasonable for most industries.
Astera Labs, Inc. Common Stock (ALAB) generated $342.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Astera Labs, Inc. Common Stock (ALAB) financial analysis — history, returns, DCA and operating performance tools
Analyst verdict, bull/bear case, risk factors and peer comparison
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates